Anne Li
Cancer Research UK announced on Friday, December 15th, the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology (CRT), and Celgene Corporation, to discover, develop and commercialise new anti-cancer treatments. This arrangement represents an expansion of Cancer Research Technology’s theme-based translational model that now encompasses six industry partnerships, including this new collaboration with Celgene.
See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2017-12-15-cancer-research-uk-announces-drug-discovery-collaboration-with-celgene-corporation
Post a comment